CNR2 and papilloma: Our data reflects this latter notion, as we found minimal differences in the immune cells within the tumor microenvironment of WT and CB2-/- mice receiving DMBA/TPA coupled with significant systemic immune alterations and significant differences in papilloma development, showing that endogenous CB2 activation is potentially altering the activity and expression of specific tumor growth factors.